|
BRAFV600E mutation (n)
|
P value
|
BANCR (n)
|
P value
|
miR-9 (n)
|
P value
|
---|
Yes
|
No
|
> 0.01
|
≤ 0.01
|
> 0.01
|
≤ 0.01
|
---|
Sex
| | |
0.471
| | |
0.742
| | |
0.475
|
Female
|
27
|
10
| |
26
|
11
| |
20
|
17
| |
Male
|
12
|
2
| |
9
|
5
| |
6
|
8
| |
Age (years)
| | |
0.497
| | |
0.221
| | |
0.180
|
≤ 45
|
23
|
9
| |
20
|
12
| |
14
|
18
| |
> 45
|
16
|
3
| |
15
|
4
| |
12
|
7
| |
Tumor location
| | |
< 0.001
| | |
0.654
| | |
0.645
|
Unilateral
|
9
|
11
| |
13
|
7
| |
11
|
9
| |
Bilateral
|
30
|
1
| |
22
|
9
| |
15
|
16
| |
Tumor size (cm/mean)
|
1.8 ± 0.7
|
1.3 ± 0.4
|
0.002
|
1.7 ± 0.8
|
1.5 ± 0.6
|
0.501
|
1.6 ± 0.8
|
1.7 ± 0.7
|
0.756
|
Multifocality
| | |
0.003
| | |
0.510
| | |
0.104
|
Single
|
7
|
8
| |
9
|
6
| |
5
|
10
| |
Multiple (≥ 2)
|
32
|
4
| |
26
|
10
| |
21
|
15
| |
Extracapsular invasion
| | |
0.004
| | |
0.036
| | |
0.121
|
No
|
14
|
10
| |
13
|
11
| |
15
|
9
| |
Yes
|
25
|
2
| |
22
|
5
| |
11
|
16
| |
Extrathyroid extension
| | |
0.173
| | |
0.694
| | |
0.140
|
No
|
31
|
12
| |
30
|
13
| |
24
|
19
| |
Yes
|
8
|
0
| |
5
|
3
| |
2
|
6
| |
Hashimoto’s disease
| | |
0.616
| | |
0.363
| | |
0.419
|
No
|
35
|
10
| |
32
|
13
| |
24
|
21
| |
Yes
|
4
|
2
| |
3
|
3
| |
2
|
4
| |
Central LNM
| | |
0.101
| | |
0.202
| | |
0.012
|
No
|
12
|
7
| |
12
|
6
| |
14
|
5
| |
Yes
|
27
|
5
| |
23
|
10
| |
12
|
20
| |
Lateral LNM
| | |
0.042
| | |
0.033
| | |
0.029
|
No
|
23
|
11
| |
20
|
14
| |
21
|
13
| |
Yes
|
16
|
1
| |
15
|
2
| |
5
|
12
| |
TNM stage
| | |
0.110
| | |
0.470
| | |
0.291
|
T1
|
17
|
9
| |
16
|
10
| |
15
|
11
| |
T2
|
14
|
3
| |
12
|
5
| |
9
|
8
| |
T3
|
8
|
0
| |
7
|
1
| |
2
|
6
| |
- BANCR BRAF-activated long non-coding RNA, LNM lymph node metastasis, TNM tumor-node-metastasis